Miyara Faical
Transaction: 06/25/2026
OTHER
Change
0
Price
Not reported
Filing
06/29/2026
Type
OTHER
Ascentage Pharma Group International
AAPG • Biotechnology
$15.89
▼ -0.03 (-0.19%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.47B
Growth
30.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 37.5%Healthy liquidity · 1.79Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 24, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$15.89
Change-0.19%
Shares Out92.60M
Market Cap$1.47B
52W Range16.36 - 48.45
Beta0.66
P/E-12.40
P/S26.84
P/B11.31
P/FCF-12.47
EV/Sales28.37
EV/EBITDA-14.47
Price$15.89
Change-0.19%
Shares Out92.60M
Market Cap$1.47B
52W Range16.36 - 48.45
Beta0.66
P/E-12.40
P/S26.84
P/B11.31
P/FCF-12.47
EV/Sales28.37
EV/EBITDA-14.47
EV/FCF-13.19
Earnings Yield-8.07%
FCF Yield-8.02%
Dividend Yield0.00%
Gross Margin76.41%
Oper. Margin-2.11%
Profit Margin-2.16%
Debt/Eq1.49
Current Ratio1.79
Quick Ratio1.77
Revenue 5Y29.98%
Target$40.00
Target Upside151.73%
Target Median$40.00
Target Range40.00 - 40.00
Volume12.11K
Avg Volume9.44K
EPS Surprise0.18
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
61/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 37.5%Healthy liquidity · 1.79Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-20
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-21
Low
$40.00
Mean
$40.00
Median
$40.00
High
$40.00
Insider Transactions
Recent executive and insider activity
Yang Dajun
Transaction: 05/21/2026
SELL
Change
-92,746
Price
Not reported
Filing
05/22/2026
Type
SELL
Yang Dajun
Transaction: 05/21/2026
BUY
Change
+92,746
Price
Not reported
Filing
05/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Miyara Faical | OTHER | 0 | Not reported | 06/25/2026 | 06/29/2026 |
| Yang Dajun | SELL | -92,746 | Not reported | 05/21/2026 | 05/22/2026 |
| Yang Dajun | BUY | +92,746 | Not reported | 05/21/2026 | 05/22/2026 |
| Zhai Yifan | SELL | -95,575 | Not reported | 05/21/2026 | 05/22/2026 |
| Zhai Yifan | BUY | +92,746 | Not reported | 05/21/2026 | 05/22/2026 |
| Yang Dajun | BUY | +298,195 | Not reported | 05/20/2026 | 05/22/2026 |
| Yang Dajun | BUY | +103,364 | $8.12 | 05/20/2026 | 05/22/2026 |
| Zhai Yifan | BUY | +103,364 | $8.12 | 05/20/2026 | 05/22/2026 |
| Zhai Yifan | BUY | +92,746 | Not reported | 05/20/2026 | 05/22/2026 |
| Misra Veet | BUY | +18,584 | Not reported | 04/20/2026 | 04/21/2026 |
| Misra Veet | OTHER | 0 | Not reported | 03/18/2026 | 04/21/2026 |
| Cao Jin | OTHER | 0 | Not reported | 03/18/2026 | 04/20/2026 |
| Cao Jin | OTHER | +12,883 | Not reported | 03/18/2026 | 04/10/2026 |
| Bozilenko Marina | OTHER | +27,965 | Not reported | 03/18/2026 | 03/23/2026 |
| Knapp Thomas J | OTHER | +38,938 | Not reported | 03/18/2026 | 03/23/2026 |
| Knapp Thomas J | OTHER | +38,938 | $8.14 | 03/18/2026 | 03/23/2026 |
| Knapp Thomas J | OTHER | 0 | Not reported | 03/18/2026 | 03/23/2026 |
| LIPPMAN MARC E | OTHER | +27,965 | Not reported | 03/18/2026 | 03/23/2026 |
| Wang Shaomeng | OTHER | +27,965 | Not reported | 03/18/2026 | 03/23/2026 |
| Wang Shaomeng | OTHER | +17,965 | $8.14 | 03/18/2026 | 03/23/2026 |